Fiji strengthens its HIV response through evidence-based harm reduction
Fiji is taking decisive steps to address a rapidly escalating HIV epidemic. Among people starting HIV treatment in 2024, 48% were people who inject drugs, highlighting the disproportionate impact on this group. As new evidence highlights unsafe injecting drug use is a major driver of transmission and exposes urgent gaps in access to prevention and stigma-free care. In Fiji, introducing needle and syringe programmes is essential to reducing transmission, protecting communities and linking people to health services that are safe, confidential and stigma-free.
This page is Both News's AI analysis of the article, not the article itself. Read the full story on the publisher's site.
Read the original articlewho.int · who.intOur verdict
Political lean
0 = center. The further from 0, the stronger the lean (max 10).
Reporting balance
How complete and even-handed the reporting is — separate from which side it leans.
This WHO feature is an institutional advocacy piece with no left/right slant, and it presents needle and syringe programmes as the settled answer to Fiji's HIV problem. Its main weakness is one-sided sourcing: four of five quoted speakers are from WHO, UNFPA or the health ministry, and the police, faith leaders and any critics of the programme are absent. Readers should treat the case figures and the effectiveness claim as unverified and look for independent Fijian sources, the full rapid assessment, and the WHO guide's evidence base.
- Why this lean
- The piece has no left/right political angle. Its slant is institutional and advocacy-driven: it presents NSPs as the settled answer and frames the workshop as progress, without any dissenting voice. Because the axis does not apply, the score stays at the center and the advocacy is described in findings.
- Framing
- A WHO and UN agency story about how Fiji is moving toward evidence-based harm reduction, with the central question being how to implement NSPs rapidly rather than whether they are needed.
Confidence: Medium — This is an institutional feature rather than a news report, so the criteria for independent sourcing and balance apply only loosely. The article does not contain the full evidence it cites, so the accuracy of its figures and the NSP effectiveness claim cannot be verified from the text alone.
Key Findings
- 1The article reports no counter-argument to NSPs: it states that 'Evidence from multiple settings show that NSPs significantly reduce HIV and hepatitis transmission ... without increasing drug use', with no study cited in the text and no mention of any dissenting evidence or political objection.
- 2Sources are concentrated in institutions: four of five quoted speakers are from WHO, UNFPA or the health ministry. The workshop is said to include 'police' and 'religious leaders', yet neither group is quoted, even though the article says their engagement is 'a critical step'.
- 3The case figures are presented as evidence of escalation without a rate, comparison period or population denominator. The reader cannot tell whether 1226 cases in six months is a rise compared with 2024, or how the 48% share compares with the infection profile of the wider population.
- 4The article does well to name the problems that matter to the people affected: it cites 'fear of arrest, discrimination and breaches of confidentiality' and gives a voice to a peer-education NGO participant, which keeps the piece from being a purely top-down account.
- 5The headline 'Fiji strengthens its HIV response' is a stronger claim than the body supports: the body describes a workshop, next steps and planned monitoring, with no outcome yet reported.
Who gets a voice
- Dr Jason MitchellChairperson, National HIV Outbreak and Cluster Response Taskforce, Fiji Ministry of Health and Medical ServicesGovernment health officialsMain voice
- Dr Mark JacobsWHO Director of Pacific Technical Support and WHO Representative to the South PacificWHO / global public health agencyMain voice
- Dr Tereza KasaevaDirector, WHO Department for HIV, TB, Hepatitis and STIsWHO / global public health agencyMain voice
- Dr Titilola Duro-AinaChief of Health and Technical Advisor-SRHR, UNFPA PacificUN agency funding the programmeMinor voice
- Anonymous workshop participantRepresentative of The Angels Collective, a peer-education programme for people who inject drugsCivil society and people who inject drugsMinor voice
Loaded language
Presents the government's actions as clearly effective before any results are reported.
Escalation is asserted, and the figures given do not show the rate of change.
Describes an NSP plan that has not yet been implemented as already essential.
Uses a UN slogan as a conclusion rather than as a measurable goal.
An advocacy term that presents the services as already stigma-free, which the article's own findings contradict.
Dimension Breakdown
Five quoted sources, four of them from WHO, UNFPA or Fiji's health ministry, plus one anonymous NGO participant. Police, religious leaders and critics are named as participants but never quoted.
Phrases such as 'decisive steps', 'rapidly escalating', 'critical programme' and 'no one is left behind' are promotional rather than neutral, though the quotes are attributed.
Case counts and the 48% figure are given without a comparison period, rate or denominator, and the claim that NSPs do 'not increase drug use' has no cited study in the text.
Health agencies and the health ministry dominate. Law enforcement, faith leaders, and opponents or sceptics of NSPs, all of whom the article itself says must be engaged, are absent from the reporting.
The headline 'strengthens its HIV response' is supported by the described workshop and plans, but no outcome is yet measured, so the word overstates what has been achieved.
The article omits Fiji's legal position on syringe programmes, the programme's funding and sustainability, and any reference to earlier NSP experience in the country, all of which a reader needs to judge the plan.
Missing Perspectives
- Law enforcement and faith leaders, who attended the workshop according to the article but are not quoted, so the reader cannot judge whether the police are on board with NSPs.
- Critics or sceptics of needle and syringe programmes, such as community or political voices who object on moral or public-order grounds; without them, the case for NSPs is presented as uncontested.
- Independent epidemiologists or data sources to test the 'multiple settings' evidence and the case figures.
- Fiji's legal status for NSPs and the funding for their sustainability, which a reader needs in order to judge how realistic the 'phased national approach' is.
Highlighted Passages
“Fiji is taking decisive steps to address a rapidly escalating HIV epidemic.”
“Evidence from multiple settings show that NSPs significantly reduce HIV and hepatitis transmission, prevent injection-related infections and provide an entry point to broader health and social services – without increasing drug use.”
“It brought together government officials, police, religious leaders, pharmacists, clinicians, civil society organizations, UN agencies, researchers and a community representative with lived experience of injecting drug use.”
“I welcome the progress toward implementation of this critical programme”
Key Facts
- According to the article, 1583 new HIV cases were reported nationally in Fiji in 2024, and 1226 cases were notified in the first six months of 2025.
- According to the article, 48% of people starting HIV treatment in 2024 were people who inject drugs.
- A joint rapid assessment commissioned by WHO and UNDP and carried out by the Kirby Institute, Fiji National University and AIVL found syringe scarcity, unsafe injecting and fear of discrimination among people who inject drugs in Suva.
- The two-day national workshop in Suva was convened and funded by UNFPA, using WHO's operational guide for needle and syringe programmes.
- Dr Tereza Kasaeva of WHO says people who inject drugs 'are often left behind in HIV responses'.
- Fiji's Ministry of Health and Medical Services, with WHO, UNAIDS, UNDP, UNFPA and partners, is implementing a HIV Surge Strategy (2024-2027) and a national HIV Outbreak Response Plan.